Loading
companiesCompany
Korean Gynecologic Oncology Group
aka KGOG, 대한부인종양연구회
The Korean Gynecologic Oncology Group is the Korean incorporated association that runs gynaecological cancer trials; in OnCo it leads a phase 2 study of progestin with a levonorgestrel intrauterine system for fertility-sparing treatment of early endometrial cancer.
Overview
The Korean Gynecologic Oncology Group (KGOG, 사단법인 대한부인종양연구회) is an incorporated association with its office at Yeongil Building, 32 Nambusunhwan-ro 333-gil, Seocho-gu, Seoul (kgog.org, which also lists its semi-annual meetings). No founding year is stated on the pages read. ClinicalTrials.gov names it lead sponsor (OTHER class) of NCT01594879 (phase 2, medroxyprogesterone acetate with a levonorgestrel-releasing intrauterine system in young women with early endometrial cancer), the trial recorded in OnCo. It has no products of its own.
Similar pages
not linked directly; found by shared links- PersonSébastien Armanet
Shares Endometrial cancer and the tag cooperative-group.
- TreatmentProgestins (megestrol acetate, medroxyprogesterone, levonorgestrel IUD)
Shares Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer, Endometrial cancer.